01609nam a2200349 a 4500 ebr10286191 CaPaEBR m u cr cn||||||||| 090925s2009 dcua sb 000 0 eng d 9780309120883 0309120888 CaPaEBR CaPaEBR (OCoLC)726823396 n-us--- RA401.A3 B74 2009eb Breakthrough business models [electronic resource] : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, 2009. 149 p. : ill. Includes bibliographical references (p. 104-105). Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries. Orphan drugs Government policy United States. Pharmaceutical policy United States. Drugs Design United States. Electronic books. local Wizemann, Theresa M. Robinson, Sally. Giffin, Robert B. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. ebrary, Inc. http://site.ebrary.com/lib/rucke/Doc?id=10286191 An electronic book accessible through the World Wide Web; click to view 17053 17053